Dr. Jorge Munoz will discuss the CDC Trioplex real-time RT-PCR assay for detection and differentiation of Zika, dengue and chikungunya virus infections in one clinical sample. To participate, please pre-register by sending an email to tto@cdc.gov by Thursday, April 26, at 1 p.m. EDT. After requesting the registration, participants will receive a confirmation of their registration along with access information to enter prior to the webinar.

 

The technology and related data are being licensed to achieve expeditious commercialization of federally funded research and development. An international (PCT) patent application has been filed to extend market coverage. CDC also seeks collaboration partners with interest in adapting the test for different equipment, point-of-care, or more rapid processing. See the Federal Register Notice at https://www.gpo.gov/fdsys/pkg/FR-2018-03-29/pdf/2018-06306.pdf for more details.